+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pediatric Interventional Cardiology Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5635381
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pediatric Interventional Cardiology Market is projected to reach USD 3.37 Billion in 2026. It is expected to continue growing at a CAGR of 14.36%, reaching USD 7.52 Billion by 2032.

Pediatric interventional cardiology is becoming a core growth area in congenital heart disease care as hospitals shift appropriate procedures from open surgery to image-guided catheter-based treatment. Congenital heart disease is consistently reported as the most common birth defect, affecting about 8 in 1,000 live births, which creates sustained demand for early diagnosis, specialized pediatric cath labs, and long-term follow-up.

Clinical priorities center on safer atrial septal defect and patent ductus arteriosus closure, balloon valvuloplasty, vessel stenting, transcatheter pulmonary valve therapy, hybrid procedures, and reintervention for children surviving complex repairs. The market is shaped by miniaturized devices, advanced imaging, multidisciplinary congenital heart teams, and expanding access in emerging health systems.

Transformative Shifts in the Pediatric Cardiology Landscape

The landscape is being reshaped by the move toward minimally invasive pediatric cardiac intervention, supported by echocardiography, fluoroscopy, cardiac MRI, CT angiography, 3D modeling, and hybrid operating environments. These tools are improving anatomical planning, procedural precision, and radiation stewardship in infants, children, and adolescents.

Transformative shifts also include greater use of multidisciplinary heart teams, outcomes registries, simulation-based training, and device designs tailored to smaller anatomies. Hospitals and manufacturers are under pressure to generate pediatric-specific evidence, navigate stricter regulatory expectations, and align reimbursement with long-term value rather than procedure volume alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is cumulatively influencing pediatric interventional cardiology by improving image analysis, workflow triage, anatomical segmentation, and decision support. AI-assisted echocardiography, CT, and MRI can help standardize measurements, identify complex anatomy, and support preprocedural planning, while predictive models may help flag higher-risk patients before catheterization.

The practical impact remains dependent on validated pediatric datasets, transparent algorithms, cybersecurity, and clinician oversight. Because children represent a smaller and more heterogeneous population than adults, AI adoption must prioritize bias testing, human-in-the-loop governance, HIPAA and GDPR compliance, and integration with registries that capture outcomes, radiation exposure, and device durability.

Key Regional Insights

Asia-Pacific combines the world’s largest pediatric population with rapid investment in tertiary cardiac centers, making access expansion a central theme in China, India, Japan, South Korea, Australia, and ASEAN markets. North America remains highly mature, supported by specialized children’s hospitals, congenital heart disease registries, structured training pathways, newborn screening programs, and early adoption of advanced imaging and transcatheter technologies.

Latin America shows strong clinical capability in major urban centers, especially Brazil and Mexico, but access varies by insurance coverage, public funding, and geographic referral networks. Europe benefits from centralized congenital heart programs, cross-border scientific collaboration, pediatric cardiac surgery and catheterization expertise, and robust regulatory oversight, while the Middle East is expanding pediatric cardiac capacity through GCC investments in specialist hospitals, national referral programs, and medical tourism. Africa faces the greatest infrastructure constraints, with gaps in prenatal and newborn screening, cath lab availability, trained staff, and affordable devices, although regional centers, humanitarian programs, and international training partnerships are improving access.

Key Group Insights

ASEAN markets are advancing through referral hubs in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, but capacity remains uneven between metropolitan and rural populations, making workforce development and referral coordination essential. The GCC is characterized by high investment in tertiary hospitals, newborn screening, and imported specialist expertise, creating demand for premium pediatric cardiology devices, procedural training, and long-term congenital heart disease follow-up programs.

The European Union benefits from coordinated clinical research, CE-mark regulation, and established congenital heart networks, although the EU Medical Device Regulation has increased evidence, traceability, and documentation requirements for pediatric devices. BRICS countries represent major procedural-access opportunities because of large birth cohorts, expanding tertiary care, and growing domestic manufacturing, while G7 nations lead in clinical research, device innovation, reimbursement sophistication, quality registries, and AI governance. NATO countries, while not a healthcare market bloc, are relevant for resilient medical supply chains, emergency readiness, cybersecurity standards, and cross-border protocols that support high-acuity pediatric cardiac care.

Key Country Insights

The United States leads in specialized pediatric cardiac centers, clinical trials, and registry-based quality improvement, while Canada emphasizes regionalized congenital care, publicly funded access, and interprovincial referral pathways. Mexico and Brazil have strong centers of excellence but face public-sector capacity constraints, late diagnosis, and referral delays, making scalable cath lab infrastructure, telehealth-supported triage, and affordable devices key priorities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established congenital heart programs, high imaging standards, neonatal screening, and specialist training, while Russia has significant clinical capacity in large cities but faces procurement and regional access variability. In Asia-Pacific, China is expanding high-volume pediatric cardiac programs and domestic device capabilities, India combines leading private centers with large unmet public demand, Japan emphasizes procedural precision and quality systems, Australia supports regionalized specialist care across a dispersed population, and South Korea is recognized for advanced hospital infrastructure, digital health maturity, and technology adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize pediatric-specific device evidence, miniaturized delivery systems, and post-market surveillance that measures safety, reintervention, radiation exposure, hemodynamic performance, and long-term durability. Partnerships with children’s hospitals, registries, and congenital heart societies can accelerate credible clinical adoption and support reimbursement discussions.

Organizations should also invest in AI governance, interoperable imaging data, simulation-based training, and regional market-access strategies. High-growth markets require affordability, local training, service support, and referral-network development, while mature markets reward differentiated outcomes, regulatory readiness, and value-based evidence demonstrating fewer complications, shorter stays, reduced repeat procedures where clinically appropriate, and improved lifetime care.

Research Methodology

This executive summary is based on triangulation of peer-reviewed cardiology literature, congenital heart disease epidemiology, professional society guidance, regulatory information, public health datasets, hospital capability indicators, and recognized sources such as health agencies, registries, and international development databases. Emphasis was placed on reproducible, data-backed, and clinically accepted insights rather than unsupported commercial claims.

The analysis reviewed disease burden, procedural adoption, technology trends, AI maturity, regional health system capacity, and country-level access patterns. Findings were validated through consistency across multiple source categories, with careful separation between established evidence, emerging clinical practice, and areas requiring further pediatric-specific validation.

Conclusion

Pediatric interventional cardiology is advancing from a specialized procedural field into a data-driven, technology-enabled pillar of lifelong congenital heart disease management. Demand is supported by persistent birth prevalence, improved survival, expanding prenatal and newborn screening, and the clinical value of less invasive catheter-based therapies.

Future competitiveness will depend on evidence quality, pediatric-focused innovation, regional access strategies, and responsible AI adoption. Stakeholders that combine clinical credibility with scalable training, regulatory discipline, resilient supply chains, and affordable care models will be best positioned to improve outcomes for children with congenital and structural heart disease.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pediatric Interventional Cardiology Market, by Product Type
7.1. Introduction
7.2. Catheters
7.2.1. Balloon Catheters
7.2.2. Diagnostic Catheters
7.3. Occlusion Devices
7.3.1. Atrial Septal Defect Occluders
7.3.2. Patent Ductus Arteriosus Occluders
7.3.3. Ventricular Septal Defect Occluders
7.4. Stents
7.4.1. Coronary Stents
7.4.2. Non Cororonary Stents
7.5. Valves
7.5.1. Balloon Valves
7.5.2. Transcatheter Heart Valves
8. Pediatric Interventional Cardiology Market, by Age Group
8.1. Introduction
8.2. Adolescents
8.3. Children
8.4. Infants
8.5. Neonates
9. Pediatric Interventional Cardiology Market, by Application
9.1. Introduction
9.2. Angioplasty
9.3. Atrial Septal Defect Closure
9.4. Patent Ductus Arteriosus Closure
9.5. Valvuloplasty
9.6. Ventricular Septal Defect Closure
10. Pediatric Interventional Cardiology Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Pediatric Interventional Cardiology Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Pediatric Interventional Cardiology Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Pediatric Interventional Cardiology Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. B. Braun Melsungen AG
15.3. Boston Scientific Corporation
15.4. CardioFocus, Inc.
15.5. Cardiovascular Systems, Inc.
15.6. Concept Medical, Inc.
15.7. Cook Medical LLC
15.8. Edwards Lifesciences Corporation
15.9. Gore Medical, Inc.
15.10. Lepu Medical Technology (Beijing) Co., Ltd.
15.11. LifeTech Scientific Corporation
15.12. LivaNova PLC
15.13. Medinol Ltd.
15.14. Medtronic plc
15.15. Merit Medical Systems, Inc.
15.16. MicroPort Scientific Corporation
15.17. Neovasc Inc.
15.18. NuMED, Inc.
15.19. Oscor, Inc.
15.20. Philips Healthcare
15.21. Relievant Medsystems, Inc.
15.22. Terumo Corporation
15.23. Transluminal Technologies, Inc.
15.24. Vascular Solutions, Inc.
15.25. W.L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BALLOON CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BALLOON CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BALLOON CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL DIAGNOSTIC CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL DIAGNOSTIC CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL DIAGNOSTIC CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL OCCLUSION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL OCCLUSION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ATRIAL SEPTAL DEFECT OCCLUDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ATRIAL SEPTAL DEFECT OCCLUDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ATRIAL SEPTAL DEFECT OCCLUDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PATENT DUCTUS ARTERIOSUS OCCLUDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PATENT DUCTUS ARTERIOSUS OCCLUDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PATENT DUCTUS ARTERIOSUS OCCLUDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL VENTRICULAR SEPTAL DEFECT OCCLUDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL VENTRICULAR SEPTAL DEFECT OCCLUDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL VENTRICULAR SEPTAL DEFECT OCCLUDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NON CORORONARY STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NON CORORONARY STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NON CORORONARY STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL BALLOON VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BALLOON VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL BALLOON VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ADOLESCENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ADOLESCENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ADOLESCENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CHILDREN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CHILDREN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CHILDREN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INFANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INFANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INFANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL NEONATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL NEONATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL NEONATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ANGIOPLASTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ANGIOPLASTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ANGIOPLASTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ATRIAL SEPTAL DEFECT CLOSURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ATRIAL SEPTAL DEFECT CLOSURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ATRIAL SEPTAL DEFECT CLOSURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PATENT DUCTUS ARTERIOSUS CLOSURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PATENT DUCTUS ARTERIOSUS CLOSURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PATENT DUCTUS ARTERIOSUS CLOSURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL VALVULOPLASTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL VALVULOPLASTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL VALVULOPLASTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL VENTRICULAR SEPTAL DEFECT CLOSURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL VENTRICULAR SEPTAL DEFECT CLOSURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL VENTRICULAR SEPTAL DEFECT CLOSURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 113. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 114. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 115. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 116. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 117. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. EUROPE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 128. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 131. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 132. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 133. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 134. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 135. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 136. AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 141. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 142. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 143. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 144. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 145. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 146. ASEAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 149. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 150. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 151. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 152. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 153. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 154. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. GCC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 168. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 169. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 170. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 171. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 172. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. BRICS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 177. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 178. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 179. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 180. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 181. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. G7 PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 186. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 187. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 188. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 189. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 190. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. NATO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 203. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 205. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 206. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 207. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 208. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 209. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 210. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 212. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 214. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 215. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 216. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 217. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 218. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 223. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 224. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 225. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 226. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 227. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 241. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 242. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 243. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 244. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 245. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 250. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 251. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 252. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 253. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 254. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 267. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 268. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 269. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 270. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 271. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 272. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 276. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 277. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 278. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 279. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 280. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 281. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 285. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 286. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 287. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 288. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 289. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 290. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 291. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 294. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 295. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 296. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 297. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 298. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 299. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 302. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 303. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 304. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 305. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 306. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 307. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 308. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 312. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 313. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 314. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 315. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 316. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 317. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 318. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 322. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY OCCLUSION DEVICES, 2017-2032 (USD MILLION)
TABLE 323. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 324. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVES, 2017-2032 (USD MILLION)
TABLE 325. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 326.

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Cardiovascular Systems, Inc.
  • Concept Medical, Inc.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Gore Medical, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LifeTech Scientific Corporation
  • LivaNova PLC
  • Medinol Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Neovasc Inc.
  • NuMED, Inc.
  • Oscor, Inc.
  • Philips Healthcare
  • Relievant Medsystems, Inc.
  • Terumo Corporation
  • Transluminal Technologies, Inc.
  • Vascular Solutions, Inc.
  • W.L. Gore & Associates, Inc.

Table Information